source
- Novo Nordisk rebrands as 'Novo' and launches new culture strategy after recent setbacksNovo Nordisk announced it will drop "Nordisk" from its public brand, opting to be known simply as "Novo" starting Monday. The name change is part of a broader cultural overhaul aimed at revitalizi…
- Axoltis Phase 2 ALS Trial Fails Primary Endpoint Though Shows Some Secondary TrendsAxoltis Pharma reported that its phase 2 study of the synthetic peptide NX210c in amyotrophic lateral sclerosis did not meet its primary goal. The double‑blind, randomized trial enrolled 82 French…